PURPOSE: To elicit and evaluate opinions in the diagnosis and management of nonparaneoplastic autoimmune retinopathy (npAIR) among members of the American Uveitis Society (AUS) and to further the development of consensus and criteria in the diagnosis and management of npAIR. We hypothesize that despite lack of any clear guidelines, a general consensus in the clinical diagnosis and treatment of npAIR exists among uveitis experts. METHODS: A literature review was performed and a panel of uveitis experts was consulted to formulate a survey regarding the diagnosis and management of npAIR. An online survey of 10 questions was developed, and a link was distributed through the AUS membership discussion list. We defined "general consensus" as meaning that a majority (>50%) of the respondents provided the same answer to a question. RESULTS: Fifty-four members of the AUS responded to the survey. Thirty-eight members (70.4%) see one to three AIR patients per year. Greater than 50% consensus was reached on most items, particularly items relating to diagnostic features and tests (up to 96% consensus). CONCLUSIONS: The diagnosis and management of npAIR is challenging, as standardized clinical and laboratory diagnostic criteria have yet to be established. The results of this study support the presence of consensus regarding certain aspects of npAIR, but also indicate the need for developing clear clinical diagnostic criteria and treatment guidelines.
PURPOSE: To elicit and evaluate opinions in the diagnosis and management of nonparaneoplastic autoimmune retinopathy (npAIR) among members of the American Uveitis Society (AUS) and to further the development of consensus and criteria in the diagnosis and management of npAIR. We hypothesize that despite lack of any clear guidelines, a general consensus in the clinical diagnosis and treatment of npAIR exists among uveitis experts. METHODS: A literature review was performed and a panel of uveitis experts was consulted to formulate a survey regarding the diagnosis and management of npAIR. An online survey of 10 questions was developed, and a link was distributed through the AUS membership discussion list. We defined "general consensus" as meaning that a majority (>50%) of the respondents provided the same answer to a question. RESULTS: Fifty-four members of the AUS responded to the survey. Thirty-eight members (70.4%) see one to three AIR patients per year. Greater than 50% consensus was reached on most items, particularly items relating to diagnostic features and tests (up to 96% consensus). CONCLUSIONS: The diagnosis and management of npAIR is challenging, as standardized clinical and laboratory diagnostic criteria have yet to be established. The results of this study support the presence of consensus regarding certain aspects of npAIR, but also indicate the need for developing clear clinical diagnostic criteria and treatment guidelines.
Authors: Richard G Weleber; Robert C Watzke; William T Shults; Karmen M Trzupek; John R Heckenlively; Robert A Egan; Grazyna Adamus Journal: Am J Ophthalmol Date: 2005-05 Impact factor: 5.258
Authors: H Nida Sen; Chi-Chao Chan; Rafael C Caruso; Robert N Fariss; Robert B Nussenblatt; Ronald R Buggage Journal: Ophthalmology Date: 2004-03 Impact factor: 12.079
Authors: Wei-Hong Xiong; Robert M Duvoisin; Grazyna Adamus; Brett G Jeffrey; Celia Gellman; Catherine W Morgans Journal: PLoS One Date: 2013-08-01 Impact factor: 3.240
Authors: Luke A Wiley; Elaine M Binkley; Adam P DeLuca; Grefachew Workalemahu; Nicole J Tatro; Meagan A Luse; Elizabeth L Kennedy; James C Folk; Todd E Scheetz; Zuhair K Ballas; Budd A Tucker; Robert F Mullins; Ian C Han; Edwin M Stone Journal: Retin Cases Brief Rep Date: 2022-01-01
Authors: Sinisa D Grozdanic; Tatjana Lazic; Helga Kecova; Kabhilan Mohan; Grazyna Adamus; Markus H Kuehn Journal: Vet Ophthalmol Date: 2020-12-27 Impact factor: 1.644